Association Between Real-Time Continuous Glucose Monitor Use and Diabetes-Related Medical Costs for Patients with Type 2 Diabetes.

导出 LinkOut

翻译打印收藏纠错

作者： Gregory J,Norman ^[1] ; Misti L,Paudel ^[2] ; Christopher G,Parkin ^[3] ; Tim,Bancroft ^[2] ; Peter M,Lynch ^[1]

作者单位： Dexcom, Inc., San Diego, California, USA. ^[1] Optum Life Sciences, Inc., Eden Prairie, Minnesota, USA. ^[2] CGParkin Communications, Inc., Henderson, Nevada, USA. ^[3]

关键词 Intensive insulin regimen Medical costs Nonintensive therapy Type 2 diabetes rtCGM

主题词血糖(Blood Glucose);血糖自我监测(Blood Glucose Self-Monitoring);糖尿病, 2型(Diabetes Mellitus, Type 2);卫生保健费用(Health Care Costs);人类(Humans);回顾性研究(Retrospective Studies)

DOI 10.1089/dia.2021.0525

PMID 35230158

发布时间 2022-08-17

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Diabetes technology & therapeutics

2022年24卷7期

520-524页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Association Between Real-Time Continuous Glucose Monitor Use and Diabetes-Related Medical Costs for Patients with Type 2 Diabetes.

Diabetes technology & therapeutics

相似文献

Diabetes technology & therapeutics

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Association Between Real-Time Continuous Glucose Monitor Use and Diabetes-Related Medical Costs for Patients with Type 2 Diabetes.

Diabetes technology & therapeutics

相似文献

Diabetes technology & therapeutics

相关期刊

检索历史清除